Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Critical Care and Intensive Care Medicine
Reference58 articles.
1. Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors.
2. Mechanism of factor VIIa–dependent coagulation in hemophilia blood
3. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor.
4. Efficacy and Safety of Recombinant Factor VIIa in the Prophylaxis of Bleeding in Various Surgical Procedures in Hemophilic Patients with Factor VIII and Factor IX Inhibitors
5. The use of recombinant factor VIIa in the treatment of bleeding disorders
Cited by 271 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Budget impact and cost-utility analysis of prophylactic emicizumab versus on-demand bypassing agents for adolescent severe haemophilia A patients with inhibitors in India;Heliyon;2024-03
2. Hemoperitoneum;Small Animal Soft Tissue Surgery;2023-03-10
3. Use of recombinant human factor VIIa in 2 patients with postoperative noncompressible, abdominal hemorrhage;Journal of Veterinary Emergency and Critical Care;2023-02-20
4. Role of Recombinant Activated Factor VIIa (rFVIIa) in Bleeding Mycotic Aneurysm of the Abdominal Aorta;Journal of the College of Physicians and Surgeons Pakistan;2022-09-01
5. Transfusion Therapy in Specific Clinical Situations;Transfusion Medicine;2021-03-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3